Basic info
Industry
pharmaceuticals
Sectors
OPD5
melphalan flufenamide
Relapsed & Relapsed-Refractory Multiple Myeloma
Multiple Myeloma
melflufen
peptide conjugated alkylator
peptidase targeting
anti-angiogenic
Orphan Drug
cytotoxicity
peptide-drug conjugate
phase 3
oncology
phase 2
phase 1
Plasma Cell Myeloma
RRMM
EMD
alkylation
efficacy studies
Date founded
2000